Summary:
A new study is looking to see how well an investigational insulin works to control blood sugar levels when taken in addition to an FDA approved, rapid-acting insulin at mealtimes. Participants will receive the study medications at no charge for the duration of the study. By taking part in this study, you could be part of making Type 1 Diabetes treatment more affordable worldwide.
Qualified Participants Must:
• Be at least 18 years old
•
Have been diagnosed with Type 1 diabetes
•
Be taking a basal-bolus insulin therapy regimen for at least 1 year
•
Be taking Lantus for at least 3 months
Qualified Participants May Receive:
- Study-related medical examinations
- Study-related investigational medication at no cost
- Compensation up to $1,050.00 for time and travel
- Diabetes testing supplies
- Diet and lifestyle counseling